Distinct mutations led to inactivation of type 1 fimbriae expression in Shigella spp

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Bravo, Verónica ^a   Puhar, Andrea ^b,c   Sansonetti, Philippe ^b,c   Parsot, Claude ^b,c   Toro, Cecilia S ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIMBRIA PROTEIN;

ADOLESCENT; ARTICLE; BACTERIAL GENE; BACTERIUM ADHERENCE; CELL INTERACTION; CELL INVASION; CHILEAN; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; FEC GENE; FIM GENE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENE SYNTHESIS; HUMAN; NONHUMAN; PROMOTER REGION; SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; YJHATS GENE; BACTERIAL GENOME; FIMBRIA; GENETICS; HELA CELL LINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIGENE FAMILY; MUTATION; OPERON;

ESCHERICHIA COLI; SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

BACTERIAL ADHESION; EPITHELIAL CELLS; FIMBRIAE, BACTERIAL; GENOME, BACTERIAL; HELA CELLS; HUMANS; MULTIGENE FAMILY; MUTATION; OPERON; SHIGELLA;

EID: 84926292108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121785     Document Type: Article

References (69)

1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999; 77:651-666. PMID: 10516787
2. Johnson TJ, Nolan LK. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev MMBR. 2009; 73:750-774. doi: 10.1128/MMBR.00015-09 PMID: 19946140
3. Buchrieser C, Glaser P, Rusniok C, Nedjari H, D'Hauteville H, Kunst F, et al. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol Microbiol. 2000; 38:760-771. PMID: 11115111
4. Parsot C. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors. FEMS Microbiol Lett. 2005; 252:11-18. doi: 10.1016/j.femsle.2005.08.046 PMID: 16182469
5. Newland JW, Strockbine NA, Miller SF, O'Brien AD, Holmes RK. Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli. Science. 1985; 230:179-181. PMID: 2994228
6. Vokes SA, Reeves SA, Torres AG, Payne SM. The aerobactin iron transport system genes in Shigella flexneri are present within a pathogenicity island. Mol Microbiol. 1999; 33:63-73. PMID: 10411724
7. Al-Hasani K, Henderson IR, Sakellaris H, Rajakumar K, Grant T, Nataro JP, et al. The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation. Infect Immun. 2000; 68:2457-2463. PMID: 10768931
8. Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol. 2000; 54:641-679. doi: 10.1146/annurev.micro.54.1.641 PMID: 11018140
9. Schmidt H, Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev. 2004; 17:14-56. PMID: 14726454
10. Escobar-Páramo P, Giudicelli C, Parsot C, Denamur E. The evolutionary history of Shigella and enteroinvasive Escherichia coli revised. J Mol Evol. 2003; 57:140-148. doi: 10.1007/s00239-003-2460-3 PMID: 14562958
11. Pupo GM, Lan R, Reeves PR. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc Natl Acad Sci U S A. 2000; 97:10567-10572. doi: 10.1073/pnas.180094797 PMID: 10954745
12. Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet P, et al. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet. 2009; 5:e1000344. doi: 10.1371/journal.pgen.1000344 PMID: 19165319
13. Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, et al. Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002; 30:4432-4441. PMID: 12384590
14. Moran NA, Plague GR. Genomic changes following host restriction in bacteria. Curr Opin Genet Dev. 2004; 14:627-633. doi: 10.1016/j.gde.2004.09.003 PMID: 15531157
15. Cooper VS, Lenski RE. The population genetics of ecological specialization in evolving Escherichia coli populations. Nature. 2000; 407:736-739. doi: 10.1038/35037572 PMID: 11048718
16. Maurelli AT. Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens. FEMS Microbiol Lett. 2007; 267:1-8. doi: 10.1111/j.1574-6968.2006.00526.x PMID: 17233672
17. Sokurenko EV, Hasty DL, Dykhuizen DE. Pathoadaptive mutations: gene loss and variation in bacterial pathogens. Trends Microbiol. 1999; 7:191-195. PMID: 10354593
18. Maurelli AT, Fernández RE, Bloch CA, Rode CK, Fasano A. "Black holes" and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc Natl Acad Sci U S A. 1998; 95:3943-3948. PMID: 9520472
19. McCormick BA, Fernandez MI, Siber AM, Maurelli AT. Inhibition of Shigella flexneri-induced transepithelial migration of polymorphonuclear leucocytes by cadaverine. Cell Microbiol. 1999; 1:143-155. PMID: 11207548
20. Prunier A-L, Schuch R, Fernández RE, Mumy KL, Kohler H, McCormick BA, et al. nadA and nadB of Shigella flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity. Microbiol Read Engl. 2007; 153:2363-2372. doi: 10.1099/mic.0.2007/006916-0 PMID: 17600080
21. Klemm P, Schembri MA. Bacterial adhesins: function and structure. Int J Med Microbiol IJMM. 2000; 290:27-35. doi: 10.1016/S1438-4221(00)80102-2
22. Orndorff PE, Falkow S. Identification and characterization of a gene product that regulates type 1 piliation in Escherichia coli. J Bacteriol. 1984; 160:61-66. PMID: 6148338
23. Kline KA, Dodson KW, Caparon MG, Hultgren SJ. A tale of two pili: assembly and function of pili in bacteria. Trends Microbiol. 2010; 18:224-232. doi: 10.1016/j.tim.2010.03.002 PMID: 20378353
24. Capitani G, Eidam O, Glockshuber R, Grütter MG. Structural and functional insights into the assembly of type 1 pili from Escherichia coli. Microbes Infect Inst Pasteur. 2006; 8:2284-2290. doi: 10.1016/j.micinf.2006.03.013 PMID: 16793308
25. Valenski ML, Harris SL, Spears PA, Horton JR, Orndorff PE. The Product of the fimI gene is necessary for Escherichia coli type 1 pilus biosynthesis. J Bacteriol. 2003; 185:5007-5011. PMID: 12897022
26. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A. 1996; 93:9827-9832. PMID: 8790416
27. Krogfelt KA, Bergmans H, Klemm P. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun. 1990; 58:1995-1998. PMID: 1971261
28. Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science. 1997; 276:607-611. PMID: 9110982
29. McClain MS, Blomfield IC, Eisenstein BI. Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol. 1991; 173:5308-5314. PMID: 1679430
30. Gally DL, Leathart J, Blomfield IC. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol Microbiol. 1996; 21:725-738. PMID: 8878036
31. Sansonetti PJ, Kopecko DJ, Formal SB. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982; 35:852-860. PMID: 6279518
32. Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun. 1986; 51:461-469. PMID: 3510976
33. Farfán MJ, Garay TA, Prado CA, Filliol I, Ulloa MT, Toro CS. A new multiplex PCR for differential identification of Shigella flexneri and Shigella sonnei and detection of Shigella virulence determinants. Epidemiol Infect. 2010; 138:525-533. doi: 10.1017/S0950268809990823 PMID: 19765332
34. Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, et al. The complete genome sequence of Escherichia coli K-12. Science. 1997; 277:1453-1462. PMID: 9278503
35. Yang F. Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res. 2005; 33:6445-6458. doi: 10.1093/nar/gki954 PMID: 16275786
36. Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003; 71:2775-2786. PMID: 12704152
37. Baker KS, Mather AE, McGregor H, Coupland P, Langridge GC, Day M, et al. The extant World War 1 dysentery bacillus NCTC1: a genomic analysis. Lancet. 2014; 384:1691-1697. doi: 10.1016/S0140-6736(14)61789-X PMID: 25441199
38. Onodera NT, Ryu J, Durbic T, Nislow C, Archibald JM, Rohde JR. Genome sequence of Shigella flexneri serotype 5a strain M90T. J Bacteriol. 2012; 194:3022. doi: 10.1128/JB.00393-12 PMID: 22582379
39. Nie H, Yang F, Zhang X, Yang J, Chen L, Wang J, et al. Complete genome sequence of Shigella flexneri 5b and comparison with Shigella flexneri 2a. BMC Genomics. 2006; 7:173. doi: 10.1186/1471-2164-7-173 PMID: 16822325
40. Zhang N, Lan R, Sun Q, Wang J, Wang Y, Zhang J, et al. Genomic portrait of the evolution and epidemic spread of a recently emerged multidrug-resistant Shigella flexneri clone in China. J Clin Microbiol. 2014; 52:1119-1126. doi: 10.1128/JCM.02669-13 PMID: 24452172
41. Ashton PM, Baker KS, Gentle A, Wooldridge DJ, Thomson NR, Dallman TJ, et al. Draft genome sequences of the type strains of Shigella flexneri held at Public Health England: comparison of classical phenotypic and novel molecular assays with whole genome sequence. Gut Pathog. 2014; 6:7. doi: 10. 1186/1757-4749-6-7 PMID: 24684748
42. Bryan A, Roesch P, Davis L, Moritz R, Pellett S, Welch RA. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect Immun. 2006; 74:1072-1083. doi: 10.1128/IAI.74.2.1072-1083.2006 PMID: 16428754
43. Fein JE. Screening of uropathogenic Escherichia coli for expression of mannose-selective adhesins: importance of culture conditions. J Clin Microbiol. 1981; 13:1088-1095. PMID: 6114111
44. Struve C, Bojer M, Krogfelt KA. Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infect Immun. 2008; 76:4055-4065. doi: 10.1128/IAI.00494-08 PMID: 18559432
45. Oaks EV, Wingfield ME, Formal SB. Plaque formation by virulent Shigella flexneri. Infect Immun. 1985; 48:124-129. PMID: 3884506
46. Yang J, Nie H, Chen L, Zhang X, Yang F, Xu X, et al. Revisiting the molecular evolutionary history of Shigella spp. J Mol Evol. 2007; 64:71-79. doi: 10.1007/s00239-006-0052-8 PMID: 17160643
47. Snellings NJ, Tall BD, Venkatesan MM. Characterization of Shigella type 1 fimbriae: expression, FimA sequence, and phase variation. Infect Immun. 1997; 65:2462-2467. PMID: 9169792
48. Godaly G, Frendéus B, Proudfoot A, Svensson M, Klemm P, Svanborg C. Role of fimbriae-mediated adherence for neutrophil migration across Escherichia coli-infected epithelial cell layers. Mol Microbiol. 1998; 30:725-735. PMID: 10094621
49. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010; 8:26-38. doi: 10.1038/nrmicro2265 PMID: 19966814
50. Clerc P, Sansonetti PJ. Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun. 1987; 55:2681-2688. PMID: 3312007
51. Mounier J, Popoff MR, Enninga J, Frame MC, Sansonetti PJ, Van Nhieu GT. The IpaC carboxyterminal effector domain mediates Src-dependent actin polymerization during Shigella invasion of epithelial cells. PLoS Pathog. 2009; 5:e1000271. doi: 10.1371/journal.ppat.1000271 PMID: 19165331
52. Bliven KA, Maurelli AT. Antivirulence genes: insights into pathogen evolution through gene loss. Infect Immun. 2012; 80:4061-4070. doi: 10.1128/IAI.00740-12 PMID: 23045475
53. Lawrence JG. Common themes in the genome strategies of pathogens. Curr Opin Genet Dev. 2005; 15:584-588. doi: 10.1016/j.gde.2005.09.007 PMID: 16188434
54. Al Mamun AA, Tominaga A, Enomoto M. Detection and characterization of the flagellar master operon in the four Shigella subgroups. J Bacteriol. 1996; 178:3722-3726. PMID: 8682772
55. Sakellaris H, Hannink NK, Rajakumar K, Bulach D, Hunt M, Sasakawa C, et al. Curli loci of Shigella spp. Infect Immun. 2000; 68:3780-3783. PMID: 10816548
56. Tominaga A, Lan R, Reeves PR. Evolutionary changes of the flhDC flagellar master operon in Shigella strains. J Bacteriol. 2005; 187:4295-4302. doi: 10.1128/JB.187.12.4295-4302.2005 PMID: 15937193
57. Paciello I, Silipo A, Lembo-Fazio L, Curcurú L, Zumsteg A, Noël G, et al. Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. Proc Natl Acad Sci U S A. 2013; 110:E4345-4354. doi: 10.1073/pnas.1303641110 PMID: 24167293
58. Gbarah A, Mirelman D, Sansonetti PJ, Verdon R, Bernhard W, Sharon N. Shigella flexneri transformants expressing type 1 (mannose-specific) fimbriae bind to, activate, and are killed by phagocytic cells. Infect Immun. 1993; 61:1687-1693. PMID: 8097492
59. Ashkar AA, Mossman KL, Coombes BK, Gyles CL, Mackenzie R. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 2008; 4:e1000233. doi: 10.1371/journal.ppat.1000233 PMID: 19057665
60. Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, Muchardt C, et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol. 2007; 8:47-56. doi: 10.1038/ni1423 PMID: 17159983
61. Ashida H, Kim M, Schmidt-Supprian M, Ma A, Ogawa M, Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol. 2010; 12:66-73; sup pp 1-9. doi: 10.1038/ncb2006 PMID: 20010814
62. Ashida H, Toyotome T, Nagai T, Sasakawa C. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol Microbiol. 2007; 63:680-693. doi: 10.1111/j.1365-2958.2006.05547.x PMID: 17214743
63. Kim DW, Lenzen G, Page A-L, Legrain P, Sansonetti PJ, Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A. 2005; 102:14046-14051. doi: 10.1073/pnas.0504466102 PMID: 16162672
64. Li H, Xu H, Zhou Y, Zhang J, Long C, Li S, et al. The phosphothreonine lyase activity of a bacterial type III effector family. Science. 2007; 315:1000-1003. doi: 10.1126/science.1138960 PMID: 17303758
65. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog. 2010; 6:e1000898. doi: 10.1371/journal.ppat.1000898 PMID: 20485572
66. Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe. 2007; 1:77-83. doi: 10.1016/j.chom.2007.02.002 PMID: 18005683
67. Sanada T, Kim M, Mimuro H, Suzuki M, Ogawa M, Oyama A, et al. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature. 2012; 483:623-626. doi: 10.1038/nature10894 PMID: 22407319
68. Sansonetti PJ, Di Santo JP. Debugging how bacteria manipulate the immune response. Immunity. 2007; 26:149-161. doi: 10.1016/j.immuni.2007.02.004 PMID: 17307704
69. Puhar A, Tronchère H, Payrastre B, Nhieu GTV, Sansonetti PJ. A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P. Immunity. 2013; 39:1121-1131. doi: 10.1016/j.immuni.2013.11.013 PMID: 24332032